[ASAP] Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.0c00457

Source: Molecular Pharmaceutics - August 17, 2020 Category: Drugs & Pharmacology Authors: Colin T. Huang †, Xin Guo‡, Cyril Bařinka§, Shawn E. Lupold∥, Martin G. Pomper†∥⊥, Kathleen Gabrielson‡, Venu Raman†⊥, Dmitri Artemov†⊥, and Sudath Hapuarachchige*† Source Type: research